Fig. 1 | Scientific Reports

Fig. 1

From: Development of a liquid overlay-based three-dimensional cell culture panel for drug screening applications

Fig. 1

Bright field acquisitions of 3D models at the end of the culture (day 14). (a) A-375 melanoma, (b) NCI-H1417 small cell lung cancer, (c) NCI-H1975 non-small cell lung cancer, (d) SK-OV-3 ovarian cancer, (e) MCF-10A non-tumorigenic breast and (f) VERO 76 kidney healthy cells were seeded at four cell concentrations, from 200 to 10,000 cells per well, with four matrix conditions, from 0% to 3%, in culture medium. To study their unicity, bright field acquisitions were made after 14 days of culture, using Cytation10MV cell analyzer (Agilent, M = 4X, scale bar = 500 μm).

Back to article page